6 Results for "

Phthalazine

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "Phthalazine" in MCE Product Catalog:

Cat. No.: HY-W002016
CAS No.: 253-52-1
Phthalazine is a chemical scaffold. Phthalazine derivatives act as VEGFR-2 inhibitors, PARP-1 inhibitors, and anticancer agents. The complex of phthalazine with silver exhibits broad-spectrum antibacterial and antifungal activities against Staphylococcus aureus, Enterococcus faecalis, Escherichia coli, Pseudomonas aeruginosa PAO1, and Candida albicans. Phthalazine derivatives possess potent vasodilatory activity. Phthalazine can be used in research related to colon adenocarcinoma, breast cancer, hypertension, diabetes, and microbial infections .
loading...
    loading...
Cat. No.: HY-W002502
CAS No.: 140924-50-1
Synonyms: Hydroquinine 1,4-Phthalazinediyl diether; 1,4-Bis(dihydroquinine)Phthalazine
(DHQ)2PHAL (Hydroquinine 1,4-phthalazinediyl diether; 1,4-Bis(dihydroquinine)phthalazine) can be used as a chiral ligand in asymmetric dihydroxylation reactions .
loading...
    loading...
Cat. No.: HY-W002016R
CAS No.: 253-52-1
Research Areas:  

Cancer

Phthalazine (Standard) is the analytical standard of Phthalazine. This product is intended for research and analytical applications. Phthalazine is a substrate for human aldehyde oxidase 1, which can lead to the production of ROS and subsequent enzyme inactivation. Phthalazine is a nitrogen-containing organic heterocyclic compound. Phthalazine exhibits antitumor activity in blood cancer, breast cancer, colon cancer, lung cancer and renal cancer .
loading...
    loading...
Cat. No.: HY-189264
Target:  

Drug Derivative

Research Areas:  

Cancer

Anticancer agent-362 is a chimeric pyrrolidinedione-pyrrolidine-phthalazine-triazole (PPPT) heterocyclic derivative with antitumor activity. Anticancer agent-362 exhibits antiproliferative activity against breast adenocarcinoma and osteosarcoma cancer cell lines, with low toxicity to normal fibroblasts. Anticancer agent-362 is predicted to be a multi-target ligand that binds to the active sites of VEGFR-2, PARP-1, and others. Anticancer agent-362 can be used in research related to breast adenocarcinoma and osteosarcoma .
loading...
    loading...
Cat. No.: HY-P11893
Research Areas:  

Cancer

PSMA-HK9 is a ligand targeting prostate-specific membrane antigen (PSMA) that binds to PSMA with high affinity, with a Kd value of 4.76 nM. PSMA-HK9 can be labeled with the diagnostic radionuclide 68Ga for imaging applications, and this labeled conjugate exhibits high tumor uptake and low normal tissue uptake in vivo. PSMA-HK9 can be labeled with the radionuclide 177Lu for targeted radionuclide studies, and this labeled conjugate possesses efficient cellular endocytosis and tumor inhibitory activity. PSMA-HK9 can be used in studies related to prostate cancer .
loading...
    loading...
Cat. No.: HY-D3441
Research Areas:  

Others

LumiPK is an environment-sensitive probe that specifically targets the liver isoform of pyruvate kinase (PKL). LumiPK exhibits high affinity for PKL with a Kd of 37 nM. LumiPK integrates the 4-sulfonamido-7-aminobenzoxadiazole (SBD) fluorophore into a phthalazine scaffold, and its fluorescence intensity changes with the polarity of the chemical environment, thereby directly reflecting protein occupancy. LumiPK binds only to the tetrameric form of PKL, with the binding site being an allosteric pocket formed at the subunit interface, and key water-mediated interactions enhance its potency; in polar environments such as buffer, its fluorescence is significantly quenched, whereas upon binding to the nonpolar allosteric pocket of PKL, its fluorescence is enhanced. In fluorescence detection, its excitation/emission wavelengths are Ex/Em = 450/550 nm .
loading...
    loading...